Astrazeneca (AZN) Receivables - Net (2016 - 2025)
Astrazeneca (AZN) has 3 years of Receivables - Net data on record, last reported at $10.2 billion in Q4 2025.
- For Q4 2025, Receivables - Net fell 21.08% year-over-year to $10.2 billion; the TTM value through Dec 2025 reached $10.2 billion, down 21.08%, while the annual FY2025 figure was $10.2 billion, 21.08% down from the prior year.
- Receivables - Net reached $10.2 billion in Q4 2025 per AZN's latest filing, down from $13.0 billion in the prior quarter.
- Across five years, Receivables - Net topped out at $13.0 billion in Q4 2024 and bottomed at $8.4 billion in Q4 2023.
- Average Receivables - Net over 3 years is $10.5 billion, with a median of $10.2 billion recorded in 2025.
- Peak YoY movement for Receivables - Net: soared 54.3% in 2024, then decreased 21.08% in 2025.
- A 3-year view of Receivables - Net shows it stood at $8.4 billion in 2023, then skyrocketed by 54.3% to $13.0 billion in 2024, then dropped by 21.08% to $10.2 billion in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Net were $10.2 billion in Q4 2025, $13.0 billion in Q4 2024, and $8.4 billion in Q4 2023.